Parkinson’s
A new 12-month project aims to improve access to specialist mental health care for people with Parkinson's facing moderate to severe mental illness. The initiative will gather experiences from patients, carers and healthcare professionals to understand barriers and explore solutions for improving support. Moderate to severe mental illness is common in Parkinson’s and includes conditions [...]
Researchers are conducting the first-large scale trial of a device which could help people with Parkinson’s Disease to walk better. Over 200 people with Parkinson’s at eight sites around the UK will test the use of a Functional Electrical Simulation (FES) device, which is already used by people with Multiple Sclerosis (MS) and those who’ve [...]
A widely used cough medicine may help slow the progression of dementia in people with Parkinson’s disease, new research suggests. The 12-month clinical trial tested Ambroxol – a drug used for decades in Europe to treat respiratory conditions – for its potential to protect brain function in people with Parkinson’s disease dementia. The study included [...]
A Phase 2a trial of a new Parkinson’s disease drug has passed an interim safety review, allowing researchers to proceed with higher dose testing. The EXIST study is assessing exidavnemab as a potential treatment for Parkinson’s disease and multiple system atrophy (MSA)—a rare disorder where nerve cells in multiple areas of the brain progressively deteriorate. [...]
NR Times explores the latest pharma and business developments in business in the world of neuro-rehab. Roche to advance Phase III development for early-stage Parkinson's disease treatment Roche has confirmed it will be advancing to the Phase 3 development of prasinezumab, an investigational anti-alpha-synuclein antibody, in early-stage Parkinson’s disease. Multiple endpoints from the [...]
Cure Parkinson’s and Alzheimer’s Research UK are working on an initiative that could pave the way for innovative neurodegenerative treatments. There is a growing recognition that tackling neurodegenerative diseases could benefit from a collaborative, cross-disease approach. Cure Parkinson's is recognising the overlap in underlying biological processes and drugs that may show potential therapeutic benefits for [...]
Bacteria in the mouth and gut may contribute to worsening memory and thinking problems in people with Parkinson’s disease, researchers have found. Specific bacterial changes appear to be linked to the progression from mild memory symptoms to dementia – a common and distressing feature of the condition – raising the possibility they could serve as [...]
A new pilot scheme offering grants of up to £3,000 will help more marginalised communities across the UK deliver physical activity sessions for people living with Parkinson’s. The Parkinson's UK pilot focuses on groups and areas where people with Parkinson’s are underrepresented in exercise and physical activity provision. The initiative will run alongside the charity’s [...]
In a new study, researchers show that some cell types in the immune system are activated more in patients who have Parkinson’s. Parkinson’s disease is best known for its effects on the central nervous system. In addition, recent scientific advances generally emphasise the role of the immune system in the presence and development of the [...]
In a new study, researchers show that some cell types in the immune system are activated more in patients who have Parkinson’s. Parkinson’s disease is best known for its effects on the central nervous system. In addition, recent scientific advances generally emphasise the role of the immune system in the presence and development of the [...]
